HEALTH● LOW1h ago · Oct 8, 2026, 2:30 PM
A rare healthcare issue both parties agree on: A solution to Alzheimer’s that can’t wait
The Hill · north america
Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer's and other dementias.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoRobert De Niro, 83-year-old actor: “At 40, I decided to take dancers as a reference: they work, practice, and exercise”ClarínHEALTH2h agoThe disease that once ravaged Europe still exists: could plague return to Spain?EuroNews [en]HEALTH2h ago27-year-old man undergoes successful gynecomastia treatment at Kurnool KIMSThe HinduHEALTH2h agoEU presses Russia for more details on suspected plague caseEuroNews [en]